 |
Dextran sulfate (inhaled, aerosolized) |
|---|---|
| Trade Name | Uendex |
| Orphan Indication | For use as an adjunct to the treatment of cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1990-10-05 00:00:00 |
| Sponsor | Kennedy & Hoidal, M.D.'s;University of Utah Health Sciences Center, 50 North Medical Drive, Room 4R240;Salt Lake City, Utah, 84132 |
